The present study examined the expression of type 1 L-amino acid transporter (LAT1) and its associated glycoprotein 4F2hc in freshly isolated renal proximal tubules and immortalized renal proximal tubular epithelial (PTE) cells from spontaneously hypertensive (SHR) and normotensive (WKY) rats. The study also examined the inward and outward transport of [14C]-L-leucine, the preferred substrate of LAT1. The abundance of LAT1 and 4F2hc was greater in SHR than in WKY, both in freshly isolated renal proximal tubules and immortalized renal proximal tubular cells. In the absence of extracellular Na+ the BCH (2-aminobicyclo(2,2,1)-heptane-2-carboxylic acid)-sensitive [14C]-L-leucine uptake in SHR PTE cells was ñ50% that observed in WKY PTE cells (77±4 vs 164±7 pmol/mg protein). In the absence of extracellular Na+ the affinity of the transporter for the substrate in WKY PTE cells was 7.7-fold that in SHR cells, as evidenced by lower K0.5 values. Gene silencing with a LAT1 siRNA and a 4F2hc siRNA signficantly reduced LAT1 and 4F2hc expression, which was accompanied by a marked reduction in Na+-independent [14C]-L-leucine uptake in both SHR and WKY PTE cells. The spontaneous and L-leucine-stimulated outward transfer of [14C]-L-leucine was Na+-independent in both SHR and WKY PTE cells. The spontaneous [14C]-L-leucine efflux was higher in WKY than in SHR PTE cells and the potency of L-leucine to stimulate [14C]-L-leucine efflux in WKY (EC50 = 9 µM) was greater than in SHR PTE cells (EC50 = 41 µM). It is concluded that the SHR kidney overexpress LAT1/4F2hc units which display low affinity for L-leucine transport.

Keywords:
LAT1, 4F2hc, Hypertension, L-leucine, Sodium
This content is only available via PDF.
© 2007 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.